Panic Disorders Industry Report 2025-2034: Market Dynamics, Trends, And Forecasts

The Panic Disorders Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Expected Panic Disorders Market Size During the Forecast Period?
In the past few years, the market size for panic disorders has seen consistent growth. The market, which is projected to expand from $10.73 billion in 2024 to $11.19 billion in 2025, is expected to grow at a compound annual growth rate (CAGR) of 4.3%. Factors contributing to the growth during the historic period include the use of antidepressant medications, heightened awareness of mental health, elevated stress levels, the availability of mental health services, and improvement in diagnostic standards.

There's a solid prediction for considerable expansion in the panic disorders market over the forthcoming years. It's anticipated that by 2029, the value will reach a substantial sum of $13.96 billion, increasing at a compound annual growth rate (CAGR) of 5.7%. This projected growth throughout this period can be credited to several contributory factors such as the rise of new pharmacological treatments, telepsychiatry services, emphasis on comorbidities, worldwide mental health drives, advanced pharmacogenomics in treatment, and public awareness programs. Notable trends projected within this period encompass digital mental health solutions, telemedicine implementation for panic disorder therapy, pharmaceutical advancements, neurobiological research, alongside remote monitoring and wearable technology.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13191

What Are the High-Growth Segments in the Panic Disorders Market?
The panic disorders market covered in this report is segmented -

1) By Type: Agoraphobia, Social Anxiety Disorder (SAD), Obsessive-Compulsive Disorder (OCD), Bipolar Disorder, Post-Traumatic Stress Disorder (PTSD), Major Depressive Disorder
2) By Treatment: Medication, Beta Blockers, Serotonin And Norepinephrine Reuptake Inhibitors (SNRIs), Benzodiazepines, Anti-Epilepsy, Other Treatments
3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administrations
4) By End Use: Hospital Pharmacies, Retailer Pharmacies, Online Pharmacy Stores

Subsegments:
1) By Agoraphobia: Situational Agoraphobia, Non-Situational Agoraphobia
2) By Social Anxiety Disorder (SAD): Performance Anxiety, Generalized Social Anxiety
3) By Obsessive-Compulsive Disorder (OCD): Contamination OCD, Harm OCD, Checking OCD, Symmetry OCD
4) By Bipolar Disorder: Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder
5) By Post-Traumatic Stress Disorder (PTSD): Acute PTSD, Chronic PTSD, Complex PTSD
6) By Major Depressive Disorder: Recurrent Major Depressive Disorder, Single Episode Major Depressive Disorder

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13191&type=smp

What Key Drivers Are Expected to Influence Future Panic Disorders Market Growth?
The boom in the patient count dealing with mental issues is anticipated to steer the growth of the panic disorder market. Such patients suffer from psychiatric disorders or mental health issues that infringe normal mental processes, emotions, and social behaviors, manifesting as panic disorder or abrupt panic attacks. Treating these mentally afflicted patients generally involves a mix of therapeutic measures, medications, and lifestyle modifications to lessen the symptoms of panic attacks, enhance the quality of life, and help them effectively deal with their condition. Specifically, the State of Mental Health in America 2022 report by Mental Health America reported that in October 2022, the count of these patients in the US ascended to 49,564,000, which is 19.86% of its total populace, from 47,132,000, or 19% in 2021. Therefore, the rise in the psychiatric patients count will fuel the expansion of the panic disorder market. Panic Disorders Market Driver: How Telehealth is Shaping the Pause Disorders Market

Which Companies Hold the Largest Share Across Different Panic Disorders Market Segments?
Major companies operating in the panic disorders market report are F. Hoffmann-La Roche Ltd., Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Eli Lilly and Company, Boehringer Ingelheim International GmbH., Baxter Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Pfizer Inc., Sun Pharmaceutical Industries Ltd., Bausch Health Companies Inc., H. Lundbeck A/S, Shionogi & Co Ltd., Recordati S.p.A, Neurocrine Biosciences Inc., Neuraxpharm, Actavis Plc., Noven Pharmaceuticals Inc., Sumitomo Pharma Co. Ltd., VistaGen Therapeutics, Valeant Pharmaceuticals International Inc., LIFECARE NEURO PRODUCTS LTD.

What Trends Are Driving Growth in The Panic Disorders Market?
Firms with heavy influence in the panic disorder market are striving to maintain their status by innovating advanced pharmaceutical solutions, like extended-release capsules. These types of medications release their active constituents steadily over a specific period, typically 12 or 24 hours. They are primarily designed for medical conditions that require prolonged medication administration. To illustrate, Granules India Ltd, a pharmaceutical company based in India, achieved an abbreviated new drug application (ANDA) acceptance from the US Food & Drug Administration (USFDA) for its Venlafaxine hydrochloride extended-release capsules in May 2023. The approved drug demonstrated bioequivalence with Effexor XR Extended-Release Capsules, an RLD produced by Upjohn US 2 LLC. The medication, Venlafaxine HCl extended-release capsules, are typically prescribed for managing conditions like generalized anxiety disorder (GAD), major depressive disorder (MDD), panic disorder (PD), and social anxiety disorder (SAD). They function by elevating the serotonin and norepinephrine levels in the brain. The starting dosage is generally 75 mg per day but may be incremented according to the doctor's evaluation.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/panic-disorders-global-market-report

What Are the Emerging Geographies for The Panic Disorders Market Growth?
North America was the largest region in the panic disorders market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the panic disorders market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Panic Disorders Market?
2. What is the CAGR expected in the Panic Disorders Market?
3. What Are the Key Innovations Transforming the Panic Disorders Industry?
4. Which Region Is Leading the Panic Disorders Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.